IL6 and breast cancer: Furthermore, IL-6 signaling has been proven to improve the survival of breast cancer stem-like cells (BCSCs), a subpopulation rich in TNBC naturally resistant to chemotherapy and perhaps also capable of avoiding immune responses [32].